$KURA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kura Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Kura Oncology, Inc.. Get notifications about new insider transactions in Kura Oncology, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | KURA | Kura Oncology, Inc ... | SCHAFER CAROL | Director | Option Exercise | A | 21.54 | 23,000 | 495,420 | 23,000 | |
| Jun 23 2021 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 21.54 | 23,000 | 495,420 | 23,000 | |
| Jun 23 2021 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 21.54 | 23,000 | 495,420 | 23,000 | |
| Jun 23 2021 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 21.54 | 23,000 | 495,420 | 23,000 | |
| Mar 17 2021 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Option Exercise | M | 19.43 | 6,250 | 121,438 | 215,625 | |
| Mar 17 2021 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Sell | S | 29.43 | 6,250 | 183,951 | 0 | 6.3 K to 0 (-100.00 %) |
| Mar 17 2021 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Buy | M | 19.43 | 6,250 | 121,438 | 6,250 | 0 to 6.3 K |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Option Exercise | A | 32.80 | 175,000 | 5,740,000 | 175,000 | |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | BASTA JAMES | Chief Legal Officer | Option Exercise | A | 32.80 | 125,000 | 4,100,000 | 125,000 | |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | FLOWERS KIRSTEN | Chief Commercial Of ... | Option Exercise | A | 32.80 | 125,000 | 4,100,000 | 125,000 | |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Option Exercise | A | 32.80 | 140,000 | 4,592,000 | 140,000 | |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | DALE STEPHEN | Chief Medical Offic ... | Option Exercise | A | 32.80 | 100,000 | 3,280,000 | 100,000 | |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 32.80 | 366,500 | 12,021,200 | 366,500 | |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | J | 0.00 | 175,000 | 0 | 1,620,017 | 1.8 M to 1.6 M (-9.75 %) |
| Dec 16 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Option Exercise | M | 19.43 | 9,375 | 182,156 | 221,875 | |
| Dec 16 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Sell | S | 40.60 | 3,125 | 126,886 | 0 | 3.1 K to 0 (-100.00 %) |
| Dec 16 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Buy | M | 19.43 | 3,125 | 60,719 | 3,125 | 0 to 3.1 K |
| Dec 16 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Sell | S | 40.60 | 6,250 | 253,781 | 0 | 6.3 K to 0 (-100.00 %) |
| Dec 16 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Buy | M | 19.43 | 6,250 | 121,438 | 6,250 | 0 to 6.3 K |
| Dec 02 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 6.15 | 11,855 | 72,908 | 90,210 | |
| Dec 02 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 6.15 | 11,855 | 72,908 | 39,951 | 28.1 K to 40 K (+42.19 %) |
| Nov 12 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Option Exercise | M | 19.43 | 6,250 | 121,438 | 231,250 | |
| Nov 12 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Sell | S | 39.43 | 6,250 | 246,438 | 0 | 6.3 K to 0 (-100.00 %) |
| Nov 12 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Buy | M | 19.43 | 6,250 | 121,438 | 6,250 | 0 to 6.3 K |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Option Exercise | M | 19.43 | 6,250 | 121,438 | 237,500 | |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Option Exercise | M | 19.43 | 6,250 | 121,438 | 243,750 | |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Sell | S | 29.43 | 6,250 | 183,938 | 0 | 6.3 K to 0 (-100.00 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Buy | M | 19.43 | 6,250 | 121,438 | 6,250 | 0 to 6.3 K |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Sell | S | 29.43 | 6,250 | 183,938 | 0 | 6.3 K to 0 (-100.00 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Buy | M | 19.43 | 6,250 | 121,438 | 6,250 | 0 to 6.3 K |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Option Exercise | M | 19.40 | 2,102 | 40,779 | 247,898 | |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Option Exercise | M | 15.47 | 7,898 | 122,182 | 105,000 | |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Sell | S | 29.00 | 10,000 | 290,000 | 0 | 10 K to 0 (-100.00 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Buy | M | 29.00 | 2,102 | 60,958 | 10,000 | 7.9 K to 10 K (+26.61 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Buy | M | 29.00 | 7,898 | 229,042 | 7,898 | 0 to 7.9 K |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 6.15 | 17,926 | 110,245 | 157,021 | |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 28.82 | 98,490 | 2,838,876 | 206,736 | 305.2 K to 206.7 K (-32.27 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 28.00 | 485 | 13,580 | 305,226 | 305.7 K to 305.2 K (-0.16 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 28.00 | 17,926 | 501,928 | 28,096 | 46 K to 28.1 K (-38.95 %) |
| Sep 15 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 6.15 | 17,926 | 110,245 | 46,022 | 28.1 K to 46 K (+63.80 %) |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 6.15 | 37,030 | 227,735 | 174,947 | |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 28.00 | 37,030 | 1,036,840 | 28,096 | 65.1 K to 28.1 K (-56.86 %) |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 6.15 | 37,030 | 227,735 | 65,126 | 28.1 K to 65.1 K (+131.80 %) |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 28.00 | 1,025 | 28,700 | 305,711 | 306.7 K to 305.7 K (-0.33 %) |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 26.00 | 50,000 | 1,300,000 | 306,736 | 356.7 K to 306.7 K (-14.02 %) |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Option Exercise | M | 15.47 | 10,000 | 154,700 | 112,898 | |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Sell | S | 26.00 | 10,000 | 260,000 | 0 | 10 K to 0 (-100.00 %) |
| Sep 10 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Buy | M | 15.47 | 10,000 | 154,700 | 10,000 | 0 to 10 K |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 215 | 1,032 | 6,945 | |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 6.15 | 22,838 | 140,454 | 211,977 | |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 6,568 | 31,526 | 7,160 | |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.37 | 23,053 | 515,788 | 28,096 | 51.1 K to 28.1 K (-45.07 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 215 | 1,032 | 51,149 | 50.9 K to 51.1 K (+0.42 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 6.15 | 22,838 | 140,454 | 50,934 | 28.1 K to 50.9 K (+81.29 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.04 | 6,568 | 144,770 | 28,096 | 34.7 K to 28.1 K (-18.95 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 6,568 | 31,526 | 34,664 | 28.1 K to 34.7 K (+23.38 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Option Exercise | M | 15.47 | 10,000 | 154,700 | 122,898 | |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Sell | S | 23.00 | 10,000 | 230,000 | 0 | 10 K to 0 (-100.00 %) |
| Aug 26 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Buy | M | 15.47 | 10,000 | 154,700 | 10,000 | 0 to 10 K |
| Aug 25 2020 | KURA | Kura Oncology, Inc ... | DALE STEPHEN | Chief Medical Offic ... | Option Exercise | A | 21.98 | 200,000 | 4,396,000 | 200,000 | |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 11,913 | 57,182 | 13,728 | |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 521 | 2,501 | 25,641 | |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 12,901 | 61,925 | 26,162 | |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.09 | 11,913 | 263,196 | 28,096 | 40 K to 28.1 K (-29.78 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 11,913 | 57,182 | 40,009 | 28.1 K to 40 K (+42.40 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.00 | 521 | 11,462 | 28,096 | 28.6 K to 28.1 K (-1.82 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 521 | 2,501 | 28,617 | 28.1 K to 28.6 K (+1.85 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.00 | 12,901 | 283,868 | 28,096 | 41 K to 28.1 K (-31.47 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 12,901 | 61,925 | 40,997 | 28.1 K to 41 K (+45.92 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | S | 22.00 | 50,000 | 1,100,000 | 356,736 | 406.7 K to 356.7 K (-12.29 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Gift | G | 0.00 | 26,041 | 0 | 1,795,017 | 1.8 M to 1.8 M (+1.47 %) |
| Aug 19 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Gift | G | 0.00 | 26,041 | 0 | 28,096 | 54.1 K to 28.1 K (-48.10 %) |
| Aug 11 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Option Exercise | M | 15.47 | 7,102 | 109,868 | 132,898 | |
| Aug 11 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Sell | S | 20.00 | 10,000 | 200,000 | 0 | 10 K to 0 (-100.00 %) |
| Aug 11 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Buy | M | 15.47 | 7,102 | 109,868 | 10,000 | 2.9 K to 10 K (+245.07 %) |
| Jun 26 2020 | KURA | Kura Oncology, Inc ... | Parks Diane L. | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
| Jun 26 2020 | KURA | Kura Oncology, Inc ... | Szela Mary T | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
| Jun 26 2020 | KURA | Kura Oncology, Inc ... | Stein Steven H | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
| Jun 26 2020 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
| Jun 26 2020 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
| Jun 26 2020 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
| Mar 17 2020 | KURA | Kura Oncology, Inc ... | BASTA JAMES | Chief Legal Officer | Option Exercise | A | 8.41 | 25,000 | 210,250 | 25,000 | |
| Feb 12 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 26,911 | 129,173 | 39,063 | |
| Feb 12 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 6.15 | 1,185 | 7,288 | 234,815 | |
| Feb 12 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 26,911 | 129,173 | 54,137 | 27.2 K to 54.1 K (+98.84 %) |
| Feb 12 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 6.15 | 1,185 | 7,288 | 27,226 | 26 K to 27.2 K (+4.55 %) |
| Feb 12 2020 | KURA | Kura Oncology, Inc ... | Martell Bridget A | Acting Chief Medica ... | Option Exercise | A | 12.22 | 50,000 | 611,000 | 50,000 | |
| Feb 12 2020 | KURA | Kura Oncology, Inc ... | Martell Bridget A | Acting Chief Medica ... | Option Exercise | A | 12.22 | 50,000 | 611,000 | 50,000 | |
| Feb 03 2020 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Option Exercise | A | 11.86 | 45,393 | 538,361 | 45,393 | |
| Feb 03 2020 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Option Exercise | A | 11.86 | 111,723 | 1,325,035 | 111,723 | |
| Feb 03 2020 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 11.86 | 393,950 | 4,672,247 | 393,950 | |
| Jan 07 2020 | KURA | Kura Oncology, Inc ... | FLOWERS KIRSTEN | Chief Commercial Of ... | Option Exercise | A | 13.85 | 250,000 | 3,462,500 | 250,000 | |
| Nov 05 2019 | KURA | Kura Oncology, Inc ... | BASTA JAMES | Chief Legal Officer | Option Exercise | A | 15.36 | 175,000 | 2,688,000 | 175,000 | |
| Oct 16 2019 | KURA | Kura Oncology, Inc ... | Parks Diane L. | Director | Option Exercise | A | 13.78 | 8,666 | 119,417 | 8,666 | |
| Oct 16 2019 | KURA | Kura Oncology, Inc ... | Parks Diane L. | Director | Option Exercise | A | 13.78 | 30,000 | 413,400 | 30,000 | |
| Aug 13 2019 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Option Exercise | A | 19.43 | 250,000 | 4,857,500 | 250,000 | |
| Aug 13 2019 | KURA | Kura Oncology, Inc ... | FORD KATHLEEN | Chief Operating Off ... | Option Exercise | A | 19.43 | 250,000 | 4,857,500 | 250,000 | |
| Jul 12 2019 | KURA | Kura Oncology, Inc ... | GUALBERTO ANTONIO | Head of Development ... | Option Exercise | M | 6.15 | 18,000 | 110,700 | 151,000 | |
| Jul 12 2019 | KURA | Kura Oncology, Inc ... | GUALBERTO ANTONIO | Head of Development ... | Sell | S | 21.11 | 18,000 | 379,903 | 339,973 | 358 K to 340 K (-5.03 %) |
| Jul 12 2019 | KURA | Kura Oncology, Inc ... | GUALBERTO ANTONIO | Head of Development ... | Buy | M | 6.15 | 18,000 | 110,700 | 357,973 | 340 K to 358 K (+5.29 %) |
| Jun 27 2019 | KURA | Kura Oncology, Inc ... | Szela Mary T | Director | Option Exercise | A | 19.55 | 13,000 | 254,150 | 13,000 | |
| Jun 27 2019 | KURA | Kura Oncology, Inc ... | Stein Steven H | Director | Option Exercise | A | 19.55 | 13,000 | 254,150 | 13,000 | |
| Jun 27 2019 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 19.55 | 13,000 | 254,150 | 13,000 | |
| Jun 27 2019 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 19.55 | 13,000 | 254,150 | 13,000 | |
| Jun 27 2019 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 19.55 | 13,000 | 254,150 | 13,000 | |
| Jan 24 2019 | KURA | Kura Oncology, Inc ... | REN PINGDA | SVP Chemistry&Pharm ... | Option Exercise | A | 15.47 | 75,000 | 1,160,250 | 75,000 | |
| Jan 24 2019 | KURA | Kura Oncology, Inc ... | North Annette | SVP, General Counse ... | Option Exercise | A | 15.47 | 100,000 | 1,547,000 | 100,000 | |
| Jan 24 2019 | KURA | Kura Oncology, Inc ... | FARNAM JOHN | Chief Operating Off ... | Option Exercise | A | 15.47 | 125,000 | 1,933,750 | 125,000 | |
| Jan 24 2019 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Option Exercise | A | 15.47 | 140,000 | 2,165,800 | 140,000 | |
| Jan 24 2019 | KURA | Kura Oncology, Inc ... | GUALBERTO ANTONIO | Head of Development ... | Option Exercise | A | 15.47 | 140,000 | 2,165,800 | 140,000 | |
| Jan 24 2019 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 15.47 | 220,000 | 3,403,400 | 220,000 | |
| Jan 10 2019 | KURA | Kura Oncology, Inc ... | EcoR1 Capital Fund Qualified, ... | 10% Owner | Buy | P | 13.16 | 83,540 | 1,099,386 | 4,408,097 | 4.3 M to 4.4 M (+1.93 %) |
| Jan 10 2019 | KURA | Kura Oncology, Inc ... | EcoR1 Capital Fund Qualified, ... | 10% Owner | Buy | P | 13.84 | 51,879 | 718,005 | 4,324,557 | 4.3 M to 4.3 M (+1.21 %) |
| Jan 10 2019 | KURA | Kura Oncology, Inc ... | EcoR1 Capital Fund Qualified, ... | 10% Owner | Buy | P | 13.82 | 78,469 | 1,084,442 | 4,272,678 | 4.2 M to 4.3 M (+1.87 %) |
| Jan 10 2019 | KURA | Kura Oncology, Inc ... | EcoR1 Capital Fund Qualified, ... | 10% Owner | Sell | S | 13.20 | 26,520 | 350,064 | 4,194,209 | 4.2 M to 4.2 M (-0.63 %) |
| Dec 13 2018 | KURA | Kura Oncology, Inc ... | EcoR1 Capital Fund Qualified, ... | 10% Owner | Buy | P | 13.89 | 25,217 | 350,264 | 4,220,729 | 4.2 M to 4.2 M (+0.60 %) |
| Dec 13 2018 | KURA | Kura Oncology, Inc ... | EcoR1 Capital Fund Qualified, ... | 10% Owner | Buy | P | 13.91 | 15,321 | 213,098 | 4,195,512 | 4.2 M to 4.2 M (+0.37 %) |
| Dec 06 2018 | KURA | Kura Oncology, Inc ... | EcoR1 Capital Fund Qualified, ... | 10% Owner | Buy | P | 13.49 | 17,079 | 230,396 | 4,180,919 | 4.2 M to 4.2 M (+0.41 %) |
| Dec 06 2018 | KURA | Kura Oncology, Inc ... | EcoR1 Capital Fund Qualified, ... | 10% Owner | Buy | P | 13.08 | 54,645 | 714,757 | 4,163,112 | 4.1 M to 4.2 M (+1.33 %) |
| Dec 06 2018 | KURA | Kura Oncology, Inc ... | EcoR1 Capital Fund Qualified, ... | 10% Owner | Buy | P | 13.97 | 48,182 | 673,103 | 4,108,467 | 4.1 M to 4.1 M (+1.19 %) |
| Nov 09 2018 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 26,041 | 124,997 | 65,974 | |
| Nov 09 2018 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 26,041 | 124,997 | 59,026 | 33 K to 59 K (+78.95 %) |
| Nov 08 2018 | KURA | Kura Oncology, Inc ... | Szela Mary T | Director | Option Exercise | A | 11.55 | 7,583 | 87,584 | 7,583 | |
| Nov 08 2018 | KURA | Kura Oncology, Inc ... | Szela Mary T | Director | Option Exercise | A | 11.55 | 30,000 | 346,500 | 30,000 | |
| Aug 22 2018 | KURA | Kura Oncology, Inc ... | GRASSO MARC | CFO, CBO | Option Exercise | A | 19.40 | 250,000 | 4,850,000 | 250,000 | |
| Jul 03 2018 | KURA | Kura Oncology, Inc ... | FARNAM JOHN | Chief Operating Off ... | Option Exercise | A | 18.45 | 115,000 | 2,121,750 | 115,000 | |
| Jun 08 2018 | KURA | Kura Oncology, Inc ... | Stein Steven H | Director | Option Exercise | A | 16.35 | 13,000 | 212,550 | 13,000 | |
| Jun 08 2018 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 16.35 | 13,000 | 212,550 | 13,000 | |
| Jun 08 2018 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 16.35 | 13,000 | 212,550 | 13,000 | |
| Jun 08 2018 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 16.35 | 13,000 | 212,550 | 13,000 | |
| Jan 26 2018 | KURA | Kura Oncology, Inc ... | REN PINGDA | SVP Chemistry&Pharm ... | Option Exercise | A | 20.00 | 43,000 | 860,000 | 43,000 | |
| Jan 26 2018 | KURA | Kura Oncology, Inc ... | North Annette | SVP, General Counse ... | Option Exercise | A | 20.00 | 70,000 | 1,400,000 | 70,000 | |
| Jan 26 2018 | KURA | Kura Oncology, Inc ... | HENSON HEIDI | Chief Financial Off ... | Option Exercise | A | 20.00 | 81,000 | 1,620,000 | 81,000 | |
| Jan 26 2018 | KURA | Kura Oncology, Inc ... | GUALBERTO ANTONIO | Head of Development ... | Option Exercise | A | 20.00 | 100,000 | 2,000,000 | 100,000 | |
| Jan 26 2018 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 20.00 | 275,000 | 5,500,000 | 275,000 | |
| Aug 23 2017 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | M | 4.80 | 27,985 | 134,328 | 92,015 | |
| Aug 23 2017 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Buy | M | 4.80 | 27,985 | 134,328 | 32,985 | 5 K to 33 K (+559.70 %) |
| Jun 12 2017 | KURA | Kura Oncology, Inc ... | Stein Steven H | Director | Option Exercise | A | 8.60 | 10,000 | 86,000 | 10,000 | |
| Jun 12 2017 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 8.60 | 10,000 | 86,000 | 10,000 | |
| Jun 12 2017 | KURA | Kura Oncology, Inc ... | Hasnain Faheem | Director | Option Exercise | A | 8.60 | 10,000 | 86,000 | 10,000 | |
| Jun 12 2017 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 8.60 | 10,000 | 86,000 | 10,000 | |
| Jan 25 2017 | KURA | Kura Oncology, Inc ... | LIU YI | Chief Scientific Of ... | Option Exercise | A | 6.15 | 63,000 | 387,450 | 63,000 | |
| Jan 25 2017 | KURA | Kura Oncology, Inc ... | REN PINGDA | SVP-Chemistry&Pharm ... | Option Exercise | A | 6.15 | 55,000 | 338,250 | 55,000 | |
| Jan 25 2017 | KURA | Kura Oncology, Inc ... | North Annette | SVP, General Counse ... | Option Exercise | A | 6.15 | 72,000 | 442,800 | 72,000 | |
| Jan 25 2017 | KURA | Kura Oncology, Inc ... | GUALBERTO ANTONIO | Chief Medical Offic ... | Option Exercise | A | 6.15 | 169,000 | 1,039,350 | 169,000 | |
| Jan 25 2017 | KURA | Kura Oncology, Inc ... | HENSON HEIDI | Chief Financial Off ... | Option Exercise | A | 6.15 | 100,000 | 615,000 | 100,000 | |
| Jan 25 2017 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 6.15 | 236,000 | 1,451,400 | 236,000 | |
| Jan 03 2017 | KURA | Kura Oncology, Inc ... | Stein Steven H | Director | Option Exercise | A | 5.60 | 3,333 | 18,665 | 3,333 | |
| Jan 03 2017 | KURA | Kura Oncology, Inc ... | Stein Steven H | Director | Option Exercise | A | 5.60 | 30,000 | 168,000 | 30,000 | |
| May 13 2016 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 3.12 | 10,000 | 31,200 | 10,000 |